Rivus Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Rivus Pharmaceuticals has a total of 45 patents globally, out of which 25 have been granted. Of these 45 patents, more than 95% patents are active. The USA is where Rivus Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the United States seems to be the main focused R&D center of Rivus Pharmaceuticals and is also the origin country of the firm.

Rivus Pharmaceuticals was founded in the year 2019 by Allen Cunningham. The company operates as a biopharmaceutical firm dedicated to improving cardio-metabolic health.

Do read about some of the most popular patents of Rivus Pharmaceuticals which have been covered by us in this article and also you can find Rivus Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Rivus Pharmaceuticals patent portfolio.

How many patents does Rivus Pharmaceuticals have?

Rivus Pharmaceuticals has a total of 45 patents globally. These patents belong to 6 unique patent families. Out of 45 patents, 43 patents are active.

How Many Patents did Rivus Pharmaceuticals File Every Year?

Rivus Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRivus Pharmaceuticals Applications FiledRivus Pharmaceuticals Patents Granted
2022316
202123
202021
201971
201828

How many Rivus Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Rivus Pharmaceuticals Patent Portfolio

How Many Patents did Rivus Pharmaceuticals File in Different Countries?

Rivus Pharmaceuticals Worldwide Patent Filing

List of Countries in which Rivus Pharmaceuticals Filed Patents

CountryPatents
United States Of America4
Europe2
Japan2
Malaysia1
Portugal1
Norway1
China1
Slovenia1
Colombia1
Mexico1
Denmark1
Philippines1
Eurasia1
Singapore1
Austria1
Spain1
Georgia1
Malta1
Hong Kong (S.A.R.)1
Morocco1
India1
Peru1
Indonesia1
Poland1
Israel1
Saudi Arabia1
Italy1
Slovakia1
Taiwan1
South Africa1

Where are Research Centres of Rivus Pharmaceuticals Patents Located?

R&D Centres of Rivus Pharmaceuticals

List of Rivus Pharmaceuticals Patents

Rivus Pharmaceuticals PatentsTitle
US10618875B2Phenyl Derivatives
US20210238144A1Phenyl Derivatives
MTP41656BNovel Phenyl Derivatives
SKE39913T3New Phenyl Derivatives
SI3565806T1Novel Phenyl Derivatives
PL3565806T3Novel Phenyl Derivatives
ES2913431T3New Phenyl Derivatives
MA47210B1New Phenyl Derivatives
DK3565806T3New Phenyl Derivs
EP3565806B1Novel Phenyl Derivatives
IT202200032792T2New Phenylderivates.
NO3565806B1Novel Phenyl Derivatives
EP4086242A15 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro L H Imidazole And Its Pharmaceutical Use
LT3565806TNovel Phenyl Derivatives
PT3565806TNovel Phenyl Derivatives
AT1472159TNew Phenyl Derivatives
CN110167918BNovel Phenyl Derivatives
WO2023150767A1Methods Of Weight Loss And Preserving Skeletal Muscle Mass
WO2023150759A1Methods Of Weight Loss In A Subject With Elevated Hba1C
WO2022246039A1Methods Of Treating Mitochondria Related Disorders
CA3047138A15 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro 1H Imidazole And Its Use In The Treatment Of Mitochondria Related Disorders
HK40018387A1Novel Phenyl Derivatives
AU2018205811B2Novel Phenyl Derivatives
MX388198BNew Phenyl Derivatives.
IL267868ANovel Phenyl Derivatives
JP7090088B2New Phenyl Derivative
JP2022120118ANew Phenyl Derivative
KR102579648B1Novel Phenyl Derivatives
IN437208BNovel Phenyl Derivatives
CL66248BThe Compound 5 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro 1H Imidazole; Composition; And Use To Treat Obesity, Diabetes, Among Other Diseases.
ZA201903808BNovel Phenyl Derivatives
EA041412B15 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro 1H Imidazole
VN10034101BPhenyl Compounds And Pharmaceuticals Containing Them
MY192778ANovel Phenyl Derivatives
SA9785B1Novel Phenyl Derivatives
IDP000079226BNew Phenyl Derivatives
GEP20217227BNovel Phenyl Derivatives
TW202313010AMethods Of Treating Mitochondria Related Disorders
BR112019013371A2New Phenyl Derivatives
PH12019501318A1Novel Phenyl Derivatives
PE0012432019A1New Phenyl Derivatives
SG11201905121YANovel Phenyl Derivatives
CO20190006865A2New Phenyl Derivatives
US20220048865A1Novel Phenyl Derivatives
US20200399225A1Novel Phenyl Derivatives

What are Rivus Pharmaceuticals’ key innovation segments?

What Technologies are Covered by Rivus Pharmaceuticals?

The chart below distributes patents filed by Rivus Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Rivus Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Rivus Pharmaceuticals’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Rivus Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.